Healthcare Services

Critical Limb Ischemia Market Size Outlook and Demand Growth Across 2026–2030

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Critical Limb Ischemia Market Over The 2026–2030 Period?

The critical limb ischemia market has experienced significant growth in recent years. It is expected to grow from $3.89 billion in 2025 to $4.25 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.3%. The market’s historical expansion can be attributed to the high prevalence of peripheral artery disease, increasing diabetes incidence, aging population growth, reliance on surgical revascularization, and delayed disease diagnosis.

The critical limb ischemia market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach a valuation of $6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. This projected growth during the forecast period can be primarily attributed to several factors: progress in vascular devices, an increase in minimally invasive procedures, the proliferation of specialized vascular centers, heightened awareness regarding limb preservation, and enhanced accessibility to diagnostic imaging. Key developments expected during this period include the increasing adoption of endovascular revascularization, greater utilization of drug-eluting devices, the advancement of limb salvage treatment methodologies, the broadening of multidisciplinary vascular care, and an emphasis on early diagnosis and intervention.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9859&type=smp

What Drivers Are Expected To Influence The Critical Limb Ischemia Market During The Forecast Period?

The critical limb ischemia treatment market is expected to experience growth driven by increasing investments in healthcare infrastructure, which involve funding the development, improvement, and maintenance of essential physical structures, facilities, and systems vital for healthcare service delivery. These investments are crucial for equipping the facilities and providing the necessary resources to effectively diagnose and treat critical limb ischemia (CLI). For instance, a report from the Office for National Statistics, a UK-based government department, published in May 2023, showed that healthcare spending in the UK increased by 5.6% between 2022 and 2023, a notable rise compared to the 0.9% growth in 2022. The UK’s total healthcare expenditure for 2023 was around $317.63 billion (£292 billion). Consequently, the rising investments in healthcare infrastructure are propelling the expansion of the critical limb ischemia treatment market.

How Is The Critical Limb Ischemia Market Segmented Across Key Categories?

The critical limb ischemia market covered in this report is segmented –

1) By Type: Devices, Drugs, Surgery

2) By Medication: Antihypertensive Agents, Antiplatelet Drugs, Antithrombotic Agents, Other Medications

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Devices: Angioplasty Balloons, Stents, Catheters, Atherectomy Devices, Implantable Devices

2) By Drugs: Antiplatelet Agents, Vasodilators, Anticoagulants, Thrombolytics, Growth Factors And Cytokines

3) By Surgery: Bypass Surgery, Endarterectomy, Amputation, Revascularization Procedures

Which Upcoming Trends Are Expected To Influence The Critical Limb Ischemia Market?

Major companies engaged in the critical limb ischemia (CLI) treatment market are developing technologically advanced products, such as bioresorbable stents, to enhance outcomes for patients dealing with this severe peripheral artery disease. These dissolving stents are engineered to provide temporary support to the affected artery and then progressively dissolve once the vessel has healed. For example, in April 2024, Abbott Laboratories, a US-based medical device company, secured approval from the Food and Drug Administration (FDA), a US federal agency, for its Esprit BTK Everolimus Eluting Resorbable Scaffold System. This dissolving stent is specifically designed for individuals experiencing chronic limb-threatening ischemia (CLTI) in arteries located below the knee, representing the first approval of such a stent for this condition in the United States. Constructed from materials similar to dissolvable sutures, the stent is intended to gradually dissolve over approximately three years after implantation, simultaneously releasing the immunosuppressive drug everolimus, which aids in preventing arterial re-narrowing and promotes vessel healing.

Who Are The Dominant Players Shaping The Critical Limb Ischemia Market Landscape?

Major companies operating in the critical limb ischemia market are Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, LimFlow SA, Micro Medical Solutions, Cardiovascular Systems Inc., Shanghai MicroPort Medical (Group) Co Ltd., B. Braun SE, Teva Pharmaceutical Industries Ltd., Cook Medical, Philips, BD, Penumbra Inc., Cardinal Health Inc., Teleflex Incorporated, AngioDynamics Inc., Endologix Inc., Terumo Corporation, MicroPort Scientific, Silk Road Medical, LeMaitre Vascular Inc., Merit Medical Systems Inc., Shockwave Medical, Avinger, Biomerics LLC, Intact Vascular Inc., Bluegrass Vascular Technologies, PQ Bypass, Rex Medical, Aortica Corporation

Read the full critical limb ischemia market report here:

https://www.thebusinessresearchcompany.com/report/critical-limb-ischemia-global-market-report

Which Region Is Forecast To Lead The Critical Limb Ischemia Market In Terms Of Market Size?

North America was the largest region in the critical limb ischemia treatment market in 2025. The regions covered in the critical limb ischemia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Critical Limb Ischemia Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9859&type=smp

Browse Through More Reports Similar to the Global Critical Limb Ischemia Market 2026, By The Business Research Company

Crispr Gene Editing Global Market Report

https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

Crispr And Cas Gene Global Market Report

https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report

Plant Breeding And Crispr Plants Global Market Report

https://www.thebusinessresearchcompany.com/report/plant-breeding-and-crispr-plants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795